Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2010, Vol. 30 Issue (11): 94-99    DOI:
    
Research Progress on Cell Engineering and Endophytes of Rare Plant Sinopodophyllum emodi(Wall.) Ying
YANG Hui1,2, GUO Qi1,2, ZHAO Chang-qi3, ZHOU Jian-ping1,2
1. Institute of Biology, Gansu Academy of Sciences, Lanzhou 730000, China;
2. Industrial Microbiology Engineering Research Center in Gansu, Lanzhou 730000, China;
3. College of Life Sciences, Beijing Normal University, Beijing 100875, China
Download: HTML   PDF(467KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

The main active ingredient of Sinopodophyllum emodi (Wall.) Ying is podophyllotoxin, which has an important application potential in medical field. Currently, the main source of podophyllotoxin for commercial production come from wild Sinopodophyllum emodi (Wall.) Ying, which has become endangered in the world for overcollecting.Both botanical characteristics of Sinopodophyllum emodi (Wall.) Ying and the research progress of podophyllotoxin production by cell engineering (such as tissue culture, rapid propagation, largescale cell culture, hairy root culture)and endophytic fungi fermentation were introduced with a view to providing background information for the related researches.



Key wordsSinopodophyllum emodi      Podophyllotoxin      Cell engineering      Endophytes     
Received: 07 July 2010      Published: 19 November 2010
ZTFLH:  Q813  
Cite this article:

YANG Hui, GUO Qi, ZHAO Chang-qi, ZHOU Jian-ping. Research Progress on Cell Engineering and Endophytes of Rare Plant Sinopodophyllum emodi(Wall.) Ying. China Biotechnology, 2010, 30(11): 94-99.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2010/V30/I11/94

[1] 应俊生.小檗科八角莲属和桃儿七属 (新属) 的研究.植物分类学报,1979, 17 (1):15-23. Ying J S. Acta Phytotaxon Sin, 1979, 17 (1):15-23.
[2] Farkya S, Bisaria V S, Srivastava A K. Biotechnological aspects of the production of the anticancer drug podophyllotoxin. Appl Microbiol Biotechnol, 2004, 65 (5): 504-519.
[3] Zhu X K, Guan J, Xiao Z,et al. Anti-HIV activity of new podophyllotoxin derivatives. Bioorg Med Chem Lett, 2004, 12 (15):4267-4273.
[4] Chen S W, Wang Y H,Jin Y, et al. Synthesis and antiHIV-1 activities of novel podophyllotoxin derivatives.Bioorg Med Chem Lett,2007, 17 (7):2091-2095.
[5] Schwartz J, Norton S A.Useful plants of dermatology VI. The mayapple (podophyllum). J Am Acad Dermatol, 2002, 47 (5):774-775.
[6] Raman C,Rajesh A,Shikha S,et al. Podophyllum hexandrum offers radioprotection by modulating radical flux:role of Aryl-tetralin Lignans.Evid Based Compleme Altern Med.2006,3(4):503-511.
[7] 张尊听,贺云,刘谦光,等.分光光度法测定太白山20种中草药的抗氧化活性.分析试验室,2002,21(2):50-52. Zhang Z T, He Y, Liu Q G, et al. Chin J Anal Lab, 2002,21(2):50-52.
[8] Lerndal T, Svensson B. A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis. Rheumatol,2000, 39 (3): 316-320.
[9] Garcia E S, Cabral M M O, Schaub G A,et al. Effects of lignoids on a hematophagous bug. Rhodnius prolixus: feeding, ecdysis and diuresis. Phytochem, 2000, 55 (6): 611-616.
[10] Oliva A, Moraes R M, Watson S B,et al. Aryltetralin lignans inhibit plant growth by affecting the formation of mitotic microtubular organizing centers. Pestic Biochem Physiol,2002, 72 (1), 45-54.
[11] Chatterjee R. Indian Podophyllum. Econ Bot, 1952, 6 (4): 342-354.
[12] Nadeem M, Palni L M S, Kumar A,et al. Podophyllotoxin content,above and belowground biomass in relation to altitude in Podophyllum hexandrum population from Kumaun region of the Indian Central Himalaya. Planta Med, 2007,73(4):388-391.
[13] Purohit A N, Lata H, Nauitiyal S,et al. Some characteristics of four morphological variants of Podophyllum hexandrum Royle. Plant Genet Resour News,1998,114: 51-52.
[14] Arumugam N,Bhojwani S S. Somatic embryogenesis in tissue cultures of Podophyllum hexandrum. Can J Bot, 1990,68(3): 487-491.
[15] 杨晖,王治业,陆栋,等.桃儿七的组织培养.植物生理学通讯, 2006, 42 (1) : 791. Yang H, Wang Z Y, Lu D, et al. Plant Physiol Commun, 2006, 42 (1) : 791.
[16] Van Uden W, Pras N, Visser J F,et al. Detection and identification of Podophyllotoxin produced by cell cultures derived from Podophyllum hexandrum royle.Plant cell Reports,1989,8: 165-168.
[17] Heyenga A G, Lucas J A, Dewick P M. Production of tumour-inhibition lignans in callus cultures of Podophyllum hexandrum. Plant Cell Rep, 1990, 9:382-385.
[18] 杨晖,王治业,陆栋,等.濒危药用植物桃/Lt的愈伤组织诱导和悬浮培养及其鬼臼毒素含量分析.In:陈贵林,杨九研,王丽红,等.第八届全国药用植物及植物药学术研讨会论文集.第八届全国药用植物及植物药学术研讨会.内蒙古:内蒙古大学, 2009:56. Yang H, Wang Z Y, Lu D, et al. Callus Induction and suspension Culture of Rare Plant Podophyllum hexandrum with the Analysis of Podophyotoxin Content. In:Chen G L,Yang Y J,Wang L H,et al. Proceedinys of Eighth National Conference on Medicinal Plants and Herbal.Eight National Conference on Medicinal Plants and Herbal. Inner Mongolia: Inner Mongolia University,2009:56.
[19] Chattopadhyay S, Srivastava A K, Bhojwani S S,et al. Development of suspension culture of Podophyllum hexandnum for production of podophyllotoxin. Biotechnol Lett, 2001,23 (24): 2063-2066.
[20] Garden H J. Biotechnological production of podophyllotoxin by Linum album suspension cultures. Duesseldorf : HeinrichHeineUniversity, 2003:25-85.
[21] Chattopadhyay S, Bisaria V S, Bhojwani S S, et al. Enhanced production of podophyllotoxin by fedbatch cultivation of Podophyllum hexandrum. Can J Chem Eng, 2003, 81(5): 1011-1018.
[22] Giri A, Giri C C, Dhingra V,et al. Enhanced podophyllotoxin production from Agrobacterium rhizogenes transformed cultures of Podophyllum hexandrum. Nat Prod Lett, 2001, 15(4):229-235.
[23] Guillon S, TrémouillauxGuiller J, Pati P K, et al. Hairy root research: recent scenario and exciting prospects. Curr opin Plant Biol, 2006, 9(3):341-346.
[24] 黄超杰,孟益聪,冯虎元.濒危药用植物桃儿七根的显微结构及其菌根真菌分布研究.菌物科学,2008,27(36):922-929. Huang C J, Meng Y C, Feng H Y. Mycosyst, 2008, 27(36):922-929.
[25] 杨显志,郭仕平,张玲琪,等.鬼臼类植物产鬼臼毒素内生真菌的筛选,天然产物研究与开发,2003,15(5):419-423. Yang X Z, Guo S P, Zhang L Q, et al. Nat Prod Res & Dev, 2003,15(5):419-423.
[26] 刘芸.几种珍稀药用植物产活性成分内生真菌的初步研究.陕西:西北大学,2005,6:27. Liu Y. Studay on Active Ingredient-prodlucing Endophytic Fungi from Scarce Chinese Medicine Plants.Shanxi: Northwest University, 2005,6:27.
[27] 张琨,黄建新,曹莉,等.桃儿七内生菌及产鬼臼类物质菌株的筛选.西北大学学报(自然科学版),2008,38(3):432-435. Zhang K,Huang JX,Cao L,et al. J Nw Univ (Nat Sci Ed ), 2008, 38 (3): 432-435.
[28] 王晓鹏,钟佳,王兴红,等.桃儿七和南山荷叶内生真菌的生物活性研究.天然产物研究与开发,2006, 18: 15-19. Wang X P, Zhong J, Wang X H,et al. Nat Prod Res & Dev, 2006, 18 (1): 15-19.
[29] 曹莉,黄建新,李建芳.桃儿七内生真菌产鬼臼毒素发酵条件研究.食品与发酵工业,2007, 33(9):28-32. Cang L,Hang J X,Li J F. Food & Ferment Ind, 2007, 33 (9):28-32.
[30] Puri S C, Nazir A, Chawla R,et al. The endophytic fungus. Trametes hirsute as a novel alternative source of podophyllotoxin and related aryltetralin lignans. J Biotechnol, 2006, 122 (4): 494-510.
[31] 王芳.鬼臼毒素高产菌株的诱变选育及发酵条件的研究,陕西:西北大学,2008,6:28-43. Wang F. Mutation Breeding and Study on Optitimize Fermentation Conditions for Strains Producing Podophyllotoxin, Shaanxi: Northwest University,2008,6:28-43.
[32] 刘星.内生真菌混合发酵产鬼臼毒素的研究.陕西:西北大学,2009,6:22-36. Liu X.Study on Endophytic Fungus’ Mixed Fermentation for Podophyllotoxin, Shaanxi: Northwest University, 2009,6:22-36.
[33] 邱敏,谢瑞生,史彧,等.植物内生真菌抗肿瘤药物研究进展.中国生物工程杂志,2009,29(1):93-104. Qiu M, Xie R S, Shi Y. et al. China Biotechnology, 2009,29 (1):93-104.
[34] Federolf K,Alfermann AW, Fuss E. Aryltetralinlignan formation in two different cell suspension cultures of Linum album: Deoxypodophyllotoxin 6-hydroxylase, a key enzyme for the formation of 6-methoxypodophyllotoxin. Phytochem, 2007, 68 (10) : 1397-1406.

[1] CHEN Ya-chao,LI Nan-nan,LIU Zi-di,HU Bing,LI Chun. Metagenomic Mining of Functional Genes Related to Glycyrrhizin Synthesis from Endophytes of Licorice[J]. China Biotechnology, 2021, 41(9): 37-47.
[2] LI Guo-kun, GAO Xiang-dong, XU Chen. Advances on Mammalian Cell Expression System[J]. China Biotechnology, 2014, 34(1): 95-100.
[3] XU Hong-ji, ZHANG Bing-bing. Gene Strategies of Enhancing the Anti-apoptosis Ability of Mammalian Cell in Engineering[J]. China Biotechnology, 2012, 32(6): 104-108.
[4] HUI Kai-yuan, GAO Xiang-dong, XU Chen. Recent Advances in Cell Engineering for Monoclonal Antibody Production[J]. China Biotechnology, 2012, 32(02): 90-95.